These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33012983)

  • 1. The valorization of non-patent intellectual property in academic medical centers.
    Marr K; Phan P
    J Technol Transf; 2020; 45(6):1823-1841. PubMed ID: 33012983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Academic Medical Centers as Innovation Ecosystems: Evolution of Industry Partnership Models Beyond the Bayh-Dole Act.
    Silva PJ; Ramos KS
    Acad Med; 2018 Aug; 93(8):1135-1141. PubMed ID: 29668523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology Transfer: From the Research Bench to Commercialization: Part 1: Intellectual Property Rights-Basics of Patents and Copyrights.
    Van Norman GA; Eisenkot R
    JACC Basic Transl Sci; 2017 Feb; 2(1):85-97. PubMed ID: 30167556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology and Protection of Intellectual Property: Emerging Trends.
    Siri JGS; Fernando CAN; De Silva SNT
    Recent Pat Nanotechnol; 2020; 14(4):307-327. PubMed ID: 32532198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent and license pearls and pitfalls for taking an idea to the marketplace.
    Mukharji I
    J Investig Med; 2011 Jun; 59(5):758-61. PubMed ID: 21441827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-IP: staring down the Bayh-Dole Act with 2020 vision.
    Paradise J
    J Law Biosci; 2020; 7(1):lsaa073. PubMed ID: 33033619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intellectual property conundrum for the biological sciences.
    Olds JL
    Anat Rec B New Anat; 2004 Mar; 277(1):5-9. PubMed ID: 15052648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology Transfer: From the Research Bench to Commercialization: Part 2: The Commercialization Process.
    Van Norman GA; Eisenkot R
    JACC Basic Transl Sci; 2017 Apr; 2(2):197-208. PubMed ID: 30167567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. University-based science and biotechnology products: defining the boundaries of intellectual property.
    Kesselheim AS; Avorn J
    JAMA; 2005 Feb; 293(7):850-4. PubMed ID: 15713775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Contrasting Perceptions and the Cause Regarding Patenting Technologies Between Academic Medical Researchers and Pharmaceutical Companies Based in Japan.
    Sugimitsu K; Manome Y
    J Multidiscip Healthc; 2021; 14():1795-1805. PubMed ID: 34285498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Academic research: policies and practice.
    Bertha SL
    J Ethnopharmacol; 1996 Apr; 51(1-3):59-73. PubMed ID: 9213631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MORE THAN MONEY: THE EXPONENTIAL IMPACT OF ACADEMIC TECHNOLOGY TRANSFER.
    McDevitt VL; Mendez-Hinds J; Winwood D; Nijhawan V; Sherer T; Ritter JF; Sanberg PR
    Technol Innov; 2014 Nov; 16(1):75-84. PubMed ID: 25061505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why did universities start patenting? Institution-building and the road to the Bayh-Dole Act.
    Berman EP
    Soc Stud Sci; 2008 Dec; 38(6):835-71. PubMed ID: 19227798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Moving research to patient applications through commercialization: understanding and evaluating the role of intellectual property.
    Patino RM
    J Am Assoc Lab Anim Sci; 2010 Mar; 49(2):147-54. PubMed ID: 20353687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the role of R&D collaborations and non-patent IP policies in government technology transfer performance: Evidence from U.S. federal agencies (1999-2016).
    Hemmatian I; Ponzio TA; Joshi AM
    PLoS One; 2022; 17(5):e0268828. PubMed ID: 35609062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intellectual property and the commercialization of research and development.
    di Norcia V
    Sci Eng Ethics; 2005 Apr; 11(2):203-19. PubMed ID: 15915860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crisis-Critical Intellectual Property: Findings From the COVID-19 Pandemic.
    Tietze F; Vimalnath P; Aristodemou L; Molloy J
    IEEE Trans Eng Manag; 2022 Oct; 69(5):2039-2056. PubMed ID: 35938060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intellectual property. University licensing and the Bayh-Dole Act.
    Thursby JG; Thursby MC
    Science; 2003 Aug; 301(5636):1052. PubMed ID: 12933996
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessment of knowledge, attitude and practice regarding intellectual property rights among dental task force attending private dental colleges in Navi Mumbai: a cross-sectional study.
    Kumar V; Aranha V; Bhanushali N; Jain R; Atre S; Singh S
    J Med Life; 2021; 14(1):93-99. PubMed ID: 33767792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Columbia University's Axel patents: technology transfer and implications for the Bayh-Dole Act.
    Colaianni A; Cook-Deegan R
    Milbank Q; 2009 Sep; 87(3):683-715. PubMed ID: 19751286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.